Research

London : The Omicron variant of SARS-CoV-2 is much less likely to lead to long Covid than the variant circulating at the start of the Covid-19 pandemic, new research shows. The study found that healthcare workers infected with the original…

Jerusalem : A team of Israeli scientists has for the first time in the world developed an mRNA vaccine that can help treat a deadly plague-causing bacteria responsible for some of the worst pandemics in human history. So far mRNA…

New York : People who have had Covid-19 are at increased risk of developing gastrointestinal (GI) disorders such as liver problems, acute pancreatitis, irritable bowel syndrome, acid reflux, and ulcers, within a year after infection…

New York : US researchers have successfully developed a blood test for anxiety that examines biomarkers to help doctors objectively determine a person's risk for developing anxiety, its severity and therapies best suited for them. "Many…

New York : A novel vaccine against deadly tuberculosis (TB) has shown to be safe and effective, according to results of the Phase 1 clinical trial. Currently, Bacille Calmette-Guerin (BCG) is the most widely administered vaccine against TB…

New York : Long-term intermittent fasting may not only help you in weight loss, but also help fight heart-related complications caused by Covid, even in patients who have both Covid and heart problems already, finds a study. Intermittent…

New York : Patients who had Covid-19 disease could be at increased risk of suffering chest pain in the six months to a year after the infection, finds a study, signalling a future risk of heart diseases. However, the study did not report…

New York : Emerging evidence suggests that Covid virus can have lasting effects on nearly every organ and organ system of the body weeks, months and potentially years after infection, an updated Centers for Disease Control and Prevention…

New York : US researchers have developed a novel Artificial Intelligence-based tool that has shown 90 per cent accuracy in detecting Alzheimer's disease from routinely collected clinical brain images. The tool, developed by a team at…

New York : The first drug designed for lowering cholesterol levels among people with statin-intolerance has shown to reduce serious cardiovascular events, according to a global study of nearly 14,000 patients. Statins have been the…